Delivery Order SPE2DB20D7059-SPE2DB23FQKH3

Award Date 9/27/23
Potential Completion Date 9/28/23
Potential Value $51
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $51,080 delivery order to Amerisourcebergen Drug Corporation for ketamine hydrochloride injection, 500 mg/5 mL vials. The firm fixed price order is for a one-day period of performance from September 25-26, 2023 at the contractor's facility in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite-delivery/indefinite-quantity contract...
The Defense Logistics Agency awarded a $51,080 delivery order to Amerisourcebergen Drug Corporation for ketamine hydrochloride injection, 500 mg/5 mL vials. The firm fixed price order is for delivery of the pharmaceutical product to a location in Conshohocken, Pennsylvania by September 22, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its corporate headquarters. As a key distributor of pharmaceuticals and medical supplies for the Department of...
The Defense Logistics Agency awarded a $51,080 delivery order to Amerisourcebergen Drug Corporation for ketamine hydrochloride injection, 500 mg/5mL vials. As part of its pharmaceutical supply chain management responsibilities for the Department of Defense, DLA issued this firm fixed price order under an existing Prime Vendor contract vehicle. Amerisourcebergen will deliver the medication to a facility in Conshohocken, Pennsylvania by September 26th to support DOD medical readiness programs....
The Defense Logistics Agency awarded a $51,080 delivery order to Amerisourcebergen Drug Corporation for ketamine hydrochloride injection, 500 mg/5 mL vials. The firm fixed price order is for delivery of the pharmaceutical product to a location in Conshohocken, Pennsylvania by September 21, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its Corporate Office Division. As a major distributor of pharmaceuticals and medical supplies to the U.S....
The Defense Logistics Agency awarded a $59,510 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketamine hydrochloride injection, 500 mg/5mL vials. As part of its pharmaceutical supply chain management responsibilities for the Department of Defense, DLA issued this order under an existing Prime Vendor contract vehicle. Amerisourcebergen will deliver the medication from its facility in Conshohocken, Pennsylvania by September 26th to support DOD medical readiness programs....
The Defense Logistics Agency awarded a $51,080 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketamine hydrochloride injection, 500 mg/5 mL vials. The single-day contract supports DLA's medical supply needs and will be performed by Amerisourcebergen at its facility in Conshohocken, Pennsylvania. No set-aside designation or subcontractors were identified. DLA manages the global supply chain for the U.S. military and ensures critical medicines and medical supplies are...
The Defense Logistics Agency awarded a $102,160 firm fixed price delivery order to AmerisourceBergen Drug Corporation for ketamine hydrochloride injection, 500 mg/5 mL vials. The delivery order was issued against an indefinite-delivery/indefinite-quantity multiple award contract vehicle to supply pharmaceutical products and services to DOD and other federal agencies. Performance will take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with all items to be delivered by...
The Defense Logistics Agency awarded a $51,080 delivery order to Amerisourcebergen Drug Corporation for ketamine hydrochloride injection, 500 mg/5 mL vials. The firm fixed price order is for a one-day period of performance from September 21-22, 2023. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the military services and combatant...
The Defense Logistics Agency awarded a $77,120 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for ketamine hydrochloride injection USP, 500 mg/5mL vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 5, 2023 in support of the Agency's medical supply needs. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $51,080 to Amerisourcebergen Drug Corporation for ketamine hydrochloride injection, 500 mg/5 mL vials. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by September 27, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified in the award...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB23FQKH3
    Delivery Order

The Defense Logistics Agency awarded a $51,080 delivery order to Amerisourcebergen Drug Corporation for ketamine hydrochloride injection, 500 mg/5 mL vials. The firm fixed price order is under the prime contractor's corporate office division and calls for delivery to a facility in Conshohocken, Pennsylvania. Performance will take place from September 27-28, 2023. The DLA supports military readiness by procuring and providing supplies to the Department of Defense and no set aside designation or subcontractors were indicated. This order for a controlled substance likely supports medical treatment programs within the military health system.

Generated 12/27/23, 9:04 AM